CNR1 and psychotic disorder: Independent of such evidence, a more recent systematic review and meta-analysis indicates higher blood and cerebrospinal fluid (CSF) endocannabinoid levels as well as higher cannabinoid receptor type 1 (CB1) expression on peripheral immune cells in psychosis patients as compared to healthy controls [20].